Clinical Trials List
2008-01-01 - 2009-06-30
Phase III
Terminated7
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 李弘元 Division of Endocrinology
- WEI-SHIUNG YANG Division of Endocrinology
- 張恬君 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林冠宏 Division of Endocrinology
- Chia-Chang Huang Division of Endocrinology
- 楊博文 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Tsueng He Division of Endocrinology
- 呂介華 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 楊純宜 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jui-Hung Sun Division of Endocrinology
- 張宏猷 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
120 participants
-
Global
1600 participants
